Optimizing Lymphodepletion to Improve Outcomes in Patients Receiving Cell Therapy With Kymriah

Clinical trial NCT06003179 · WITHDRAWN

Trial details

NCT number: NCT06003179
Sponsor: University Health Network, Toronto
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse

Start date: 2024-04-05
Primary completion: 2026-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.